Work

A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer

Year: 2021

Type: article

Study design: Observational Study

Abstract: To compare clinical, immunohistochemical and gene expression models of prognosis applicable to formalin-fixed, paraffin-embedded blocks in a large series of estrogen receptor positive breast cancers, from patients uniformly treated with adjuvant tamoxifen.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/t54c-p495

Authors: Davies, Sherri R., Ebbert, Mark, Mardis, Elaine R., Ellis, Matthew J., Voduc, David, Leung, Samuel, Reed, Jerry, Snider, Jacqueline, Bernard, Philip S., Cheang, Maggie C.U., Parker, Joel S., Nielsen, Torsten O., Vickery, Tammi, Stijleman, Inge J., Perou, Charles M.

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Susan G. Komen for the Cure, Breast Cancer Research Foundation, Sanofi, Huntsman Cancer Institute, ARUP Institute for Clinical and Experimental Pathology, Alvin J. Siteman Cancer Center, Michael Smith Health Research BC, BC Cancer Agency, National Cancer Institute

Awards: G108258030, G1114310655, G1192507251, G12431752, G1517530671, G2407663899, G299873027, G5110743314, G8242737674, G861276625, G870117454

OpenAlex ID: W4299512812

FWCI:

Cites:

Cited by:

Related to: 10